期刊文献+

2型糖尿病肾病患者肾血流阻力指数与血清脂蛋白a对肾功能进展的预测 被引量:11

Prediction of Renal Function Progression in Patients with Type 2 Diabetic Kidney Disease by Renal Blood Flow Resistance Index and Lipoprotein a
下载PDF
导出
摘要 目的研究双肾血流阻力指数(RI)、血清脂蛋白a[Lp(a)]和2型糖尿病肾病(diabetic kidney disease,DKD)肾功能损害程度三者之间的关系,探讨RI联合Lp(a)在评估糖尿病肾病肾功能进展及预后的价值.方法使用Logistic回归分析2型DN患者中eGFR下降的相关危险因素.采用RI分为两组,比较RI升高组、正常组之间的人口学指标、检验指标及双肾多普勒彩超结果的差异,使用Pearson相关分析RI与各指标之间的相关性,采用Logistic回归分析RI升高的相关危险因素,比较RI升高组、Lp(a)升高组与RI合并Lp(a)升高组的差异,采用生存分析研究RI并Lp(a)升高对2型DKD预后的影响.结果2型DKD患者中eGFR下降的相关危险因素分析提示糖尿病病程、24h尿蛋白定量、RI的升高是2型DKD患者eGFR下降的独立危险因素.RI正常组与RI升高组各项临床参数比较提示RI与DKD之间有密切关系,且发现RI与Lp(a)之间有密切关系.RI与各临床参数的相关性分析进一步证实了RI与Lp(a)和eGFR之间都有显著的相关性,RI升高的相关危险因素分析提示Lp(a)、年龄、血肌酐的升高是RI升高的独立危险因素,RI并Lp(a)升高组与其余各组间临床参数比较提示RI并Lp(a)升高组相较于其他组在eGFR、右肾体积、尿d1微球蛋白水平较低,尿β2微球蛋白水平较高,差异有统计学意义(P<0.05).RI并Lp(a)升高对DN患者肾功能预后的影响生存分析提示RI合并Lp(a)升高的患者组肾脏生存率显著低于非双升组[RI或Lp(a)未升高组],差异有统计学意义(P<0.05).结论Lp(a)可以独立预测RI升高,RI可以独立预测2型糖尿病肾病肾功能进展,RI联合Lp(a)的检测可作为糖尿病肾病进展的标志物,肾功能下降早期行降脂蛋白a治疗的临床意义更大. Objective To research the relations between the renal blood flow resistance index(RI),serum lipoprotein a[Lp(a)]and type 2 diabetic kidney disease kidney damage.To explore the value of RI combined with Lp(a)in the evaluation of renal function progression and prognosis of diabetic nephropathy.Methods Logistic regression was used to analyze the risk factors related to eGFR decline in type 2 DKD patients.The RI group was divided into two groups,and the differences in the demographic indexes,examination indexes and doppler ultrasound results between the RI elevated group and the normal group were compared.Pearson correlation analysis was used to analyze the correlation between RI and each indicator.Logistic regression was used to analyze the related risk factors of RI increase.The differences between the RI elevated group,Lp(a)elevated group and the RI combined Lp(a)elevated group were compared.Survival analysis was used to study the effect of elevated RI and Lp(a)on the prognosis of DN.Results The analysis of related risk factors for eGFR decline in type 2 DKD patients suggests that the course of diabetes mellitus,24-hour urine protein quantification,and RI increase are independent risk factors for eGFR decline in type 2 DKD patients.The comparison of clinical parameters between the normal RI group and the elevated RI group suggested that there was a close relationship between RI and DKD,and RI was found to be closely related to Lp(a).Correlation analysis between RI and various clinical parameters further confirmed that RI was significantly correlated with Lp(a)and eGFR.The analysis of related risk factors for RI elevation suggests that Lp(a),age,and serum creatinine elevation are independent risk factors for RI elevation.The comparison of clinical parameters between the RI and Lp(a)elevated group and the other groups indicated that the elevated RI and Lp(a)raised group had lower eGFR,right kidney volume,higher urinary 1 microglobulin level and higher urinary 2 microglobulin level than the other groups,and the difference was statistically significant(P<0.05).The influence of RI with Lp(a)increase on renal function prognosis of DKD patients survival analysis suggests that renal survival rate of patients with RI with Lp(a)increase was significantly lower than that of non-double-rise group[RI or Lp(a)not increased group],and the difference is statistically significant(P V.0.05).Conclusion Lp(a)can independently predict the elevation of RI,and RI can independently predict the progression of renal function in type 2 diabetic kidney disease.The detection of RI combined with Lp(a)can be used as a marker for the progression of diabetic kidney disease.The clinical significance of lowering lipoprotein a in the early stage of renal function decline is greater.
作者 赵凡 丁国华 Zhao Fan;Ding Guohua(Department of Nephrology,Renmin Hospital,Hubei University,Hubei 430060,China;不详)
出处 《医学研究杂志》 2019年第11期24-30,共7页 Journal of Medical Research
基金 国家自然科学基金资助项目(81570617,81770687) 国家重点研发计划项目(2016YFC1305503)
关键词 2型糖尿病肾病 肾血流阻力指数 脂蛋白A 预后 Diabetic kidney disease type 2 Renal blood flow resistance index Lipoprotein a Prognosis
  • 相关文献

参考文献3

二级参考文献55

  • 1江中林,姜国良.TGF-β_1在糖尿病肾病早期诊断中的应用[J].放射免疫学杂志,2005,18(3):195-196. 被引量:21
  • 2Clarke R, Peden JF, Hopewell JC, et al. Genetic variants as- sociated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361: 2518-2528.
  • 3El-Gendi SS, Bakeet MY, E1-Hamed EA, et al. The value of lipoprotein (a), homocysteine, and Doppler of carotid and femoral arteries in assessment of atherosclerosis in asympto-matic cardiovascular risk patients. J Cardiol 2008; 52: 202-211.
  • 4Tr6gou~t DA, K6nig IR, Erdmann J, et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2- LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41: 283-285.
  • 5Argraces KM, Korzasky KF, Fallon JJ, et al. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 1997; 100: 2170-2178.
  • 6Wu HD, Berglund L, Dimayuga C, et al. High lipoprotein (a) levels and small apolipoprotein (a) sizes are associated with endothelial dysfunction in a multiethnic cohort. J Am Coil Cardio12004;43(10): 1828 1833.
  • 7Calmarza P, Vella JC. Lipids, lipoproteins and lipoprotein (a) isoformes in type 2 diabetic patients. J Cardiovas Risk 1999; 6: 171 175.
  • 8Hoogeveen RC, Gambhir JK, Gambhir DS, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001; 42: 631-638.
  • 9Chasman DI, Shiffman D, Zee RY, et al. Polimorphism in the apolipoprotein (a) gene, plasma lipoprotein (a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 2009; 203: 371-376.
  • 10Suk Danik J, Rifai N, Buring JE, et al. Lipoprotein(a), meas- ured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 2006; 296: 1363-1370.

共引文献1485

同被引文献102

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部